SGAM

Smith Group Asset Management Portfolio holdings

AUM $1.53B
1-Year Return 38.67%
This Quarter Return
+13.92%
1 Year Return
+38.67%
3 Year Return
5 Year Return
10 Year Return
AUM
$2.38B
AUM Growth
-$459M
Cap. Flow
-$774M
Cap. Flow %
-32.45%
Top 10 Hldgs %
33.74%
Holding
420
New
42
Increased
61
Reduced
145
Closed
52

Sector Composition

1 Technology 34.34%
2 Healthcare 16.07%
3 Consumer Discretionary 11.28%
4 Communication Services 10.91%
5 Industrials 10.1%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
MOV icon
226
Movado Group
MOV
$431M
$137K 0.01%
6,314
TITN icon
227
Titan Machinery
TITN
$482M
$137K 0.01%
9,243
ANIP icon
228
ANI Pharmaceuticals
ANIP
$2.07B
$134K 0.01%
2,180
ICPT
229
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$130K 0.01%
1,050
QIWI
230
DELISTED
QIWI PLC
QIWI
$130K 0.01%
6,730
SNBR icon
231
Sleep Number
SNBR
$220M
$129K 0.01%
+2,610
New +$129K
MRTX
232
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$122K 0.01%
950
IMMU
233
DELISTED
Immunomedics Inc
IMMU
$118K ﹤0.01%
5,560
IOVA icon
234
Iovance Biotherapeutics
IOVA
$901M
$116K ﹤0.01%
4,190
OSUR icon
235
OraSure Technologies
OSUR
$236M
$112K ﹤0.01%
14,001
AMPY icon
236
Amplify Energy
AMPY
$155M
$106K ﹤0.01%
16,100
PTCT icon
237
PTC Therapeutics
PTCT
$4.55B
$106K ﹤0.01%
2,200
FGEN icon
238
FibroGen
FGEN
$48.9M
$104K ﹤0.01%
97
ZUMZ icon
239
Zumiez
ZUMZ
$366M
$104K ﹤0.01%
3,020
EBS icon
240
Emergent Biosolutions
EBS
$404M
$97K ﹤0.01%
1,790
HALO icon
241
Halozyme
HALO
$8.76B
$95K ﹤0.01%
5,350
BOLD
242
DELISTED
Audentes Therapeutics, Inc
BOLD
$94K ﹤0.01%
1,570
HBCP icon
243
Home Bancorp
HBCP
$440M
$92K ﹤0.01%
2,340
BSRR icon
244
Sierra Bancorp
BSRR
$412M
$90K ﹤0.01%
3,105
ARCT icon
245
Arcturus Therapeutics
ARCT
$485M
$86K ﹤0.01%
7,890
BGS icon
246
B&G Foods
BGS
$374M
$86K ﹤0.01%
+4,812
New +$86K
RARE icon
247
Ultragenyx Pharmaceutical
RARE
$3.07B
$85K ﹤0.01%
2,000
EGRX
248
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$82K ﹤0.01%
1,372
FOLD icon
249
Amicus Therapeutics
FOLD
$2.46B
$81K ﹤0.01%
8,280
JPM icon
250
JPMorgan Chase
JPM
$809B
$80K ﹤0.01%
574
-10
-2% -$1.39K